


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
-4.46%
+2.16%
+2.05%
META
Meta Platforms
$660.62
Strengths

Earnings are forecast to grow

Upgraded on attractively valued

Trading below its fair value

Outperform the market
META Price Performance
$656.96 (+0.56%)
$705.3 (-6.33%)
$782.13 (-15.54%)
$674.33 (-2.03%)
META has Low risk level based on volatility, sector strength, volume, investor confidence and outlook.
Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

Investors losing confidence

META overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates

Reported a strong earnings

Revenue increase YoY

Loss widens YoY
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Price value has negative momentum
Activity
Activity

Investors confidence is positive
Future
Future

Earnings are forecast to grow

Trading below its fair value

Outperform the market
![]()
META Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
META Street Sentiment is extremely bullish and have positive views on the near-term outlook
Average key support and resistance price levels
GOOG
314.55
-0.87%
PINS
27.07
+2.11%
WB
10.69
-0.74%
TRIP
14.70
-0.41%
BIDU
146.42
-2.18%
What is META current stock price?
What are META stock strengths?
What is META Risk Level?
What is META market cap and volume?
What is META current Stock IQ?
Should I buy META stock right now?
Is META a Strong Buy right now?
What does a 'Strong Buy' rating mean for META?
What does a 'Strong Sell' rating mean for META?
What factors influence META's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
-4.46%
+2.16%
+2.05%
META
Meta Platforms
Current Price
$660.62
Stock Insights
Strengths

Earnings are forecast to grow

Upgraded on attractively valued

Trading below its fair value

Outperform the market
Linked to META
GOOG
314.55
-0.87%
PINS
27.07
+2.11%
WB
10.69
-0.74%
TRIP
14.70
-0.41%
BIDU
146.42
-2.18%

META Price Performance
$656.96 (+0.56%)
$705.3 (-6.33%)
$782.13 (-15.54%)
$674.33 (-2.03%)
META Analysts Opinion
META Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates

Reported a strong earnings

Revenue increase YoY

Loss widens YoY
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Price value has negative momentum
Activity
Activity

Investors confidence is positive
Future
Future

Earnings are forecast to grow

Trading below its fair value

Outperform the market
![]()
META Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
META Street Sentiment is extremely bullish and have positive views on the near-term outlook
META has Low risk level based on volatility, sector strength, volume, investor confidence and outlook.
Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

Investors losing confidence

Average key support and resistance price levels
META Stock IQ
META Latest Analysis
Meta hires Microsoft exec former Trump deputy as chief legal officer. Meta said Tuesday that it hired former Microsoft legal executive Curtis Joseph Mahoney to become its chief legal officer.
Today
Meta Pauses Global Rollout Of $799 Ray-Ban Display Glasses As United States Demand Outstrips Supply . (RTTNews) - Meta (META) has postponed the international launch of its Ray-Ban Display AI glasses citing limited inventories and unexpectedly strong demand in the United States.
Today
Meta Pauses Global Launch Of Ray-Ban Smart Glasses After US Rush. META) is delaying its planned international rollout of the Ray-Ban Display as demand in the United States has rapidly outpaced supply forcing the company to rethink its global launch timeline.Meta had initially targeted early 2026 launches in markets including the United Kingdom France Italy and Canada. However strong domestic demand has pushed United States customer waitlists “.”. prompting the company to prioritize fu
Today
Ziihera® (zanidatamab-hrii) Combinations Achieve Unprecedented Results in First-Line HER2 Locally Advanced or Metastatic GEA including more than Two Years Median Overall Survival Benefit. VANCOUVER British Columbia Jan. 06 2026 (GLOBE NEWSWIRE) -- . (Nasdaq: ZYME) a biotechnology company managing a portfolio of licensed healthcare assets while developing a diverse pipeline of novel multifunctional biotherapeutics today announced positive efficacy and safety results from the Phase 3 HERIZON-GEA-0
Today
Meta Pauses Global Rollout For Ray-Ban Display Smart Glasses Citing Strong United States Demand.
Today
EssilorLuxottica surges after report flags strong demand for Meta RayBan glasses.
Today
Meta delays international expansion of Ray-Ban Display glasses after pointing to sizzling United States demand.
Today
Meta delays Ray-Ban Display glasses global rollout due to inventory limits United States demand. Meta CEO Mark Zuckerberg unveiled the $799 smart glasses in September.
Today
NovaBridge Reports Positive Phase 1b Results For Givastomig In Metastatic Gastric Cancer . (RTTNews) - NovaBridge Biosciences (NBP) on Tuesday reported positive updated results from its Phase 1b combination study of givastomig with nivolumab and chemotherapy in patients with HER2-negative first-line metastatic gastric cancer.
Today
The Zacks Analyst Blog Meta Bank of America The Procter & Gamble Espey and NeurAxis. Meta Platforms leads today???s Zacks Research Daily as AI-driven engagement and ad demand fuel growth even as heavy AI investments raise monetization concerns.
Today
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
META Stock trends
META Stock performance
META Stock analysis
META investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.